Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AMGN crawled date : 2021 - 03 - 30 save search
Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies
Published: 2021-03-30 (Crawled : 22:00) - prnewswire.com
PFE A | $25.615 0.89% 9.9M
|
Health Technology
|
| O: 0.11%
H: 0.77%
C: 0.22%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -1.55%
H: 0.51%
C: -0.22%
BDX | $234.6 0.62% 220K
|
Health Technology
|
| O: -0.01%
H: 0.25%
C: -0.82%
VCEL | $43.38 -1.09% 70K
|
Health Technology
|
| O: 0.74%
H: 5.83%
C: 4.75%
QURE | $4.67 -0.85% 64K
|
Health Technology
|
| O: -0.81%
H: 4.45%
C: 2.03%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.7%
H: 4.08%
C: 2.25%
BLUE | $0.9601 0.75% 1.9M
|
Health Technology
|
| O: 0.66%
H: 5.38%
C: 4.65%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: -0.21%
H: 0.29%
C: -0.17%
gene therapies gene therapy therapy drug device drug delivery liver
SomaLogic to go public via SPAC in deal that values it as a unicorn
Published: 2021-03-30 (Crawled : 08:23) - spacfeed.com
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.6%
H: 0.52%
C: 0.22%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: -0.7%
H: 0.33%
C: -1.35%
spac
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.3022 24.82% 51M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.